If you havent switched up your sourcing, prescribing, and how you talk to patients, youre in the danger zone
If a provider determines IGF-1 LR3 is appropriate for you, responsible use looks nothing like the forums
Clinical approach considerations: Patient selection: Stable post-surgical patients with inadequate weight loss, weight regain, or persistent metabolic disease Timing: Individualized based on weight trajectory and metabolic status, often when weight loss plateaus or regain is documented Baseline evaluation: Comprehensive metabolic panel, nutritional markers (vitamin B12, iron studies, vitamin D, calcium, albumin), HbA1c if diabetic, lipid panel, assessment of gastrointestinal symptoms, renal function Dosing strategy: For Wegovy, initiate at 0.25 mg weekly with gradual titration (0.250.51.01.72.4 mg)
Access to BPC-157 varies by state and pharmacy
Being prepared can help you manage them: Constipation: Increase hydration, incorporate gentle movement, and discuss fiber options (like soluble, non-fermentable fibers) with your doctor or dietitian
